Literature DB >> 19342545

Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease.

T Yoshiura1, A Hiwatashi, K Yamashita, Y Ohyagi, A Monji, Y Takayama, E Nagao, H Kamano, T Noguchi, H Honda.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral hemodynamics abnormality in Alzheimer disease (AD) is not fully understood. Our aim was to determine whether regional hypoperfusion due to AD is associated with abnormalities in regional arterial blood volume (rABV) and regional arterial transit time (rATT) as measured by quantitative arterial spin-labeling (ASL) with multiple-delay time sampling.
MATERIALS AND METHODS: Nineteen patients with AD (9 men and 10 women; mean age, 74.5 +/- 8.6 years) and 22 cognitively healthy control subjects (11 men and 11 women; mean age, 72.8 +/- 6.8 years) were studied by using a quantitative ASL method with multiple-delay time sampling. From the ASL data, maps of regional cerebral blood flow (rCBF), rABV, and rATT were generated. A region of hypoperfusion due to AD was determined by statistical parametric mapping (SPM) analysis. Mean rCBF, rABV, and rATT values within the hypoperfused region were compared between the AD and control groups.
RESULTS: Despite the significantly lower rCBF (P = .0004) in patients with AD (27.8 +/- 7.1 mL/100 g/min) in comparison with control subjects (36.7 +/- 6.3 mL/100 g/min), no significant difference in rATT was observed between the control (0.48 +/- 0.09 seconds) and AD (0.47 +/- 0.10 seconds) groups. Mean rABV was lower in the AD group (0.22 +/- 0.10%) than in the control group (0.27 +/- 0.12%), though the difference did not reach the level of statistical significance.
CONCLUSIONS: Our results revealed that regional hypoperfusion in AD is not associated with rATT prolongation, suggesting that the mechanism of hypoperfusion is distinct from that in cerebrovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342545     DOI: 10.3174/ajnr.A1562

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  47 in total

Review 1.  The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia.

Authors:  Costantino Iadecola
Journal:  Acta Neuropathol       Date:  2010-07-11       Impact factor: 17.088

2.  The VEGF gene polymorphism impacts brain volume and arterial blood volume.

Authors:  Hikaru Takeuchi; Hiroaki Tomita; Yasuyuki Taki; Yoshie Kikuchi; Chiaki Ono; Zhiqian Yu; Atsushi Sekiguchi; Rui Nouchi; Yuka Kotozaki; Seishu Nakagawa; Carlos Makoto Miyauchi; Kunio Iizuka; Ryoichi Yokoyama; Takamitsu Shinada; Yuki Yamamoto; Sugiko Hanawa; Tsuyoshi Araki; Keiko Kunitoki; Yuko Sassa; Ryuta Kawashima
Journal:  Hum Brain Mapp       Date:  2017-04-12       Impact factor: 5.038

3.  Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions.

Authors:  David A Wolk; John A Detre
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

4.  Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.

Authors:  Erik S Musiek; Yufen Chen; Marc Korczykowski; Babak Saboury; Patricia M Martinez; Janet S Reddin; Abass Alavi; Daniel Y Kimberg; David A Wolk; Per Julin; Andrew B Newberg; Steven E Arnold; John A Detre
Journal:  Alzheimers Dement       Date:  2011-10-21       Impact factor: 21.566

Review 5.  State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications.

Authors:  Magalie Viallon; Victor Cuvinciuc; Benedicte Delattre; Laura Merlini; Isabelle Barnaure-Nachbar; Seema Toso-Patel; Minerva Becker; Karl-Olof Lovblad; Sven Haller
Journal:  Neuroradiology       Date:  2015-04-10       Impact factor: 2.804

6.  Noninvasive optical monitoring of critical closing pressure and arteriole compliance in human subjects.

Authors:  Wesley B Baker; Ashwin B Parthasarathy; Kimberly P Gannon; Venkaiah C Kavuri; David R Busch; Kenneth Abramson; Lian He; Rickson C Mesquita; Michael T Mullen; John A Detre; Joel H Greenberg; Daniel J Licht; Ramani Balu; W Andrew Kofke; Arjun G Yodh
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-25       Impact factor: 6.200

7.  Optimized simultaneous ASL and BOLD functional imaging of the whole brain.

Authors:  Vincent J Schmithorst; Luis Hernandez-Garcia; Jennifer Vannest; Akila Rajagopal; Greg Lee; Scott K Holland
Journal:  J Magn Reson Imaging       Date:  2013-09-24       Impact factor: 4.813

8.  Regional cerebral arterial transit time hemodynamics correlate with vascular risk factors and cognitive function in men with coronary artery disease.

Authors:  B J MacIntosh; W Swardfager; A D Robertson; E Tchistiakova; M Saleem; P I Oh; N Herrmann; B Stefanovic; K L Lanctôt
Journal:  AJNR Am J Neuroradiol       Date:  2014-08-21       Impact factor: 3.825

9.  Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease.

Authors:  Quan Zhang; Randall B Stafford; Ze Wang; Steven E Arnold; David A Wolk; John A Detre
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 10.  Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations.

Authors:  Kenzo Koizumi; Gang Wang; Laibaik Park
Journal:  Cell Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.